The effectiveness of 0.5 mg and 1mg of semaglutide in patients with type two diabetes and predictors of response: A retrospective cohort study
S Alenzi, A Alzahrani, A Aljaloud, K Alanazi… - Frontiers in …, 2024 - frontiersin.org
Background Semaglutide is a glucagon-like peptide-1 receptor agonists (GLP-1-RAs)
approved for the treatment of type 2 diabetes mellitus (T2DM) at doses up to 1 mg. The …
approved for the treatment of type 2 diabetes mellitus (T2DM) at doses up to 1 mg. The …
Knowledge, Attitude, and Practice Level of Using Diabetes Medication to Lose Weight for Non-Diabetic Patients
K AlGamdi, F AlQahtani, A AlShangiti… - Archives of Pharmacy …, 2022 - archivepp.com
Obesity is the worst pandemic the world is facing currently as it has been proven to be the
root of all other life-threatening conditions and is difficult to treat and manage. Anti-diabetic …
root of all other life-threatening conditions and is difficult to treat and manage. Anti-diabetic …